Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.74 USD | -1.28% | +6.81% | -40.77% |
04-29 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
04-26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.77% | 2.19B | |
+62.70% | 3.02B | |
+115.18% | 703M | |
+6.10% | 475M | |
-66.87% | 144M | |
-32.23% | 85.14M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Credit Suisse Lowers Teladoc's Price Target to $27 From $30, Keeps Neutral Rating